Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siow Ming Lee

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|July 18, 2014
Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastasesSiow Ming Lee, Conrad R Lewanski, Nicholas Counsell, et al.
Plos One|February 8, 2014
A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?Ravindra K Gupta, Michael Marks, Simon G Edwards, et al.
Journal of the National Cancer Institute|July 18, 2009
Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trialSiow Ming Lee, Penella J Woll, Robin Rudd, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2021
Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancerDavid A Moore, Sarah Benafif, Benjamin Poskitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade gliomaMichael Brada, Sally Stenning, Rhian Gabe, et al.
The Lancet. Respiratory Medicine|March 23, 2020
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trialGary Middleton, Kristian Brock, Joshua Savage, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapySiow Ming Lee, Sunil Upadhyay, Conrad Lewanski, et al.
Leukemia & Lymphoma|December 5, 2012
A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphomaShireen Kassam, Mark Bower, Siow Ming Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)Martin Forster, Allan Hackshaw, Tommaso De Pas, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|July 18, 2014
Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastasesSiow Ming Lee, Conrad R Lewanski, Nicholas Counsell, et al.
Plos One|February 8, 2014
A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?Ravindra K Gupta, Michael Marks, Simon G Edwards, et al.
Journal of the National Cancer Institute|July 18, 2009
Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trialSiow Ming Lee, Penella J Woll, Robin Rudd, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2021
Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancerDavid A Moore, Sarah Benafif, Benjamin Poskitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade gliomaMichael Brada, Sally Stenning, Rhian Gabe, et al.
The Lancet. Respiratory Medicine|March 23, 2020
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trialGary Middleton, Kristian Brock, Joshua Savage, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapySiow Ming Lee, Sunil Upadhyay, Conrad Lewanski, et al.
Leukemia & Lymphoma|December 5, 2012
A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphomaShireen Kassam, Mark Bower, Siow Ming Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)Martin Forster, Allan Hackshaw, Tommaso De Pas, et al.
Pageof 5